Industry News - Tag: Bayer Consumer Health

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Bayer Consumer Health sees double-digit growth
Premium

11 November 2021

Worldwide sales at Bayer Consumer Health rose by 10.9% on a currency- and portfolio-adjusted basis to EUR1.35 billion (USD1.52 billion) in the third quarter of 2021, driven by double-digit growth for the Nutritionals and Pain & Cardio product categories.

Read the full story

People in brief | Johnson & Johnson, Bayer, FHCP

14 October 2021

Johnson & Johnson (J&J) has announced the retirement of Paul Stoffels, Bayer Consumer Health’s Mike Knowland has joined the Board of the Proprietary Association of Great Britain (PAGB), and Food, Health & Consumer Products of Canada (FHCP) has a new chair.

Read the full story

Bayer sees improvement in North America
Premium

12 August 2021

Bayer Consumer Health said its North American business had performed “very well” in the second quarter of 2021, thanks to a strong allergy season, continued high demand for Nutritionals and the launch of AleveX.

Read the full story

Products in brief | Biotrue, AleveX, Maxigesic

15 July 2021

Bausch Health Companies has extended its Biotrue eyecare brand in the US, Bayer Consumer Health is backing the launch of AleveX with a golf-themed campaign, and AFT Pharmaceuticals has received regulatory approval for Maxigesic Oral Liquid in two countries.

Read the full story

Bayer switches Astepro Allergy to OTC status in US
Premium

18 June 2021

The US Food and Drug Administration (FDA) has approved the switch of Astepro (azelastine hydrochloride 0.15%) from prescription-to-OTC status. Bayer said its Astepro Allergy Nasal Spray would be available at national mass retail locations in the first quarter of 2022.

Read the full story